Several options open for Cordlife after failed takeover of StemLife


One of the cryo containers that store umbilical cord blood and bone marrow samples at the private cord blood bank StemLife Bhd in Kuala Lumpur. The samples are kept in the stacked metal boxes to the left of the cylinder.

PETALING JAYA: It will be interesting to see the next step Singapore-listed Cordlife Group Ltd will take after the failed takeover of StemLife Bhd.

At this point in time, Cordlife has updated the market that it had received valid acceptances that gave it an 89.88% equity interest in StemLife on Tuesday.

The Star Christmas Special Promo: Save 35% OFF Yearly. T&C applies.

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Business , Cordlife , Stemlife , privatisation

Next In Business News

Great views, great premiums
Recent fires expose glaring oversights
Let’s get it right about BTS 10:90
IMF evaluation reflects Malaysia’s strong economic fundamentals, economists say
MATRADE appoints Abu Bakar Yusof as CEO
Ringgit poised to see profit-taking after hitting near six-year high vs greenback
Political clarity could unlock valuation multiples
Racing to deliver
The illusion of beat estimates
Concerns cloud vision for smart eyewear�

Others Also Read